Literature DB >> 22521631

Regional cortical thinning in patients with major depressive disorder: a surface-based morphometry study.

Pei-Chi Tu1, Li-Fen Chen, Jen-Chuen Hsieh, Ya-Mai Bai, Cheng-Ta Li, Tung-Ping Su.   

Abstract

This study uses surfaced-based morphometry to investigate cortical thinning and its functional correlates in patients with major depressive disorder (MDD). Subjects with MDD (N=36) and healthy control subjects (N=36) were enrolled in the study. Each subject received T1 structural magnetic resonance imaging (MRI), clinical evaluations, and neuropsychological examinations of executive functions with the Color Trail Test (CTT) and the Wisconsin Card Sorting Test (WCST). This study used an automated surface-based method (FreeSurfer) to measure cortical thickness and to generate the thickness maps for each subject. Statistical comparisons were performed using a general linear model. Compared with healthy controls, subjects with MDD showed the largest area of cortical thinning in the prefrontal cortex. This study also noted smaller areas of cortical thinning in the bilateral inferior parietal cortex, left middle temporal gyrus, left entorhinal cortex, left lingual cortex, and right postcentral gyrus. Regression analysis demonstrated cortical thinning in several frontoparietal regions, predicting worse executive performance measured by CTT 2, though the patterns of cortical thickness/executive performance correlation differed in healthy controls and MDD subjects. In conclusion, the results provide further evidence for the significant role of a prefrontal structural deficit and an aberrant structural/functional relationship in patients with MDD.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22521631     DOI: 10.1016/j.pscychresns.2011.07.011

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  47 in total

1.  Stability of Cortical Thinning in Persons at Increased Familial Risk for Major Depressive Disorder Across 8 Years.

Authors:  Xuejun Hao; Ardesheer Talati; Stewart A Shankman; Jun Liu; Jurgen Kaiser; Craig E Tenke; Virginia Warner; David Semanek; Priya J Wickramaratne; Myrna M Weissman; Jonathan Posner
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-10

2.  Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder.

Authors:  Elizabeth A Bartlett; Christine DeLorenzo; Priya Sharma; Jie Yang; Mengru Zhang; Eva Petkova; Myrna Weissman; Patrick J McGrath; Maurizio Fava; R Todd Ogden; Benji T Kurian; Ashley Malchow; Crystal M Cooper; Joseph M Trombello; Melvin McInnis; Phillip Adams; Maria A Oquendo; Diego A Pizzagalli; Madhukar Trivedi; Ramin V Parsey
Journal:  Neuropsychopharmacology       Date:  2018-06-19       Impact factor: 7.853

3.  Test-retest reliability of freesurfer measurements within and between sites: Effects of visual approval process.

Authors:  Zafer Iscan; Tony B Jin; Alexandria Kendrick; Bryan Szeglin; Hanzhang Lu; Madhukar Trivedi; Maurizio Fava; Patrick J McGrath; Myrna Weissman; Benji T Kurian; Phillip Adams; Sarah Weyandt; Marisa Toups; Thomas Carmody; Melvin McInnis; Cristina Cusin; Crystal Cooper; Maria A Oquendo; Ramin V Parsey; Christine DeLorenzo
Journal:  Hum Brain Mapp       Date:  2015-05-28       Impact factor: 5.038

4.  Development and evaluation of a multimodal marker of major depressive disorder.

Authors:  Jie Yang; Mengru Zhang; Hongshik Ahn; Qing Zhang; Tony B Jin; Ien Li; Matthew Nemesure; Nandita Joshi; Haoran Jiang; Jeffrey M Miller; Robert Todd Ogden; Eva Petkova; Matthew S Milak; Mary Elizabeth Sublette; Gregory M Sullivan; Madhukar H Trivedi; Myrna Weissman; Patrick J McGrath; Maurizio Fava; Benji T Kurian; Diego A Pizzagalli; Crystal M Cooper; Melvin McInnis; Maria A Oquendo; Joseph John Mann; Ramin V Parsey; Christine DeLorenzo
Journal:  Hum Brain Mapp       Date:  2018-08-16       Impact factor: 5.038

5.  Fetal exposure to maternal depressive symptoms is associated with cortical thickness in late childhood.

Authors:  Curt A Sandman; Claudia Buss; Kevin Head; Elysia Poggi Davis
Journal:  Biol Psychiatry       Date:  2014-07-10       Impact factor: 13.382

Review 6.  Prefrontal cortex and executive functions in healthy adults: a meta-analysis of structural neuroimaging studies.

Authors:  Peng Yuan; Naftali Raz
Journal:  Neurosci Biobehav Rev       Date:  2014-02-23       Impact factor: 8.989

7.  Cortical thickness is not associated with current depression in a clinical treatment study.

Authors:  Greg Perlman; Elizabeth Bartlett; Christine DeLorenzo; Myrna Weissman; Patrick McGrath; Todd Ogden; Tony Jin; Phillip Adams; Madhukar Trivedi; Benji Kurian; Maria Oquendo; Melvin McInnis; Sarah Weyandt; Maurizio Fava; Crystal Cooper; Ashley Malchow; Ramin Parsey
Journal:  Hum Brain Mapp       Date:  2017-06-08       Impact factor: 5.038

8.  In Silico Preliminary Association of Ammonia Metabolism Genes GLS, CPS1, and GLUL with Risk of Alzheimer's Disease, Major Depressive Disorder, and Type 2 Diabetes.

Authors:  Jeddidiah W D Griffin; Ying Liu; Patrick C Bradshaw; Kesheng Wang
Journal:  J Mol Neurosci       Date:  2018-02-13       Impact factor: 3.444

9.  Cortical abnormalities and association with symptom dimensions across the depressive spectrum.

Authors:  Marc S Lener; Prantik Kundu; Edmund Wong; Kaitlin E Dewilde; Cheuk Y Tang; Priti Balchandani; James W Murrough
Journal:  J Affect Disord       Date:  2015-10-30       Impact factor: 4.839

Review 10.  Structural and functional neuroimaging studies in major depressive disorder with psychotic features: a critical review.

Authors:  Geraldo F Busatto
Journal:  Schizophr Bull       Date:  2013-04-24       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.